DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 93 filers reported holding DERMIRA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $347,000 | +207.1% | 22,892 | +29.9% | 0.00% | – |
Q3 2019 | $113,000 | -32.7% | 17,621 | 0.0% | 0.00% | – |
Q2 2019 | $168,000 | -8.2% | 17,621 | +30.7% | 0.00% | – |
Q1 2019 | $183,000 | -96.1% | 13,486 | -98.0% | 0.00% | -100.0% |
Q4 2018 | $4,751,000 | -63.3% | 660,866 | -44.4% | 0.01% | -55.6% |
Q3 2018 | $12,951,000 | +17.5% | 1,188,156 | -0.8% | 0.03% | +17.4% |
Q2 2018 | $11,020,000 | +23.7% | 1,197,773 | +7.5% | 0.02% | +21.1% |
Q1 2018 | $8,907,000 | -71.3% | 1,114,709 | -0.2% | 0.02% | -70.8% |
Q4 2017 | $31,072,000 | -21.6% | 1,117,290 | -23.9% | 0.06% | -23.5% |
Q3 2017 | $39,639,000 | +10.8% | 1,468,126 | +19.6% | 0.08% | +6.2% |
Q2 2017 | $35,783,000 | +37.9% | 1,227,948 | +61.4% | 0.08% | +35.6% |
Q1 2017 | $25,944,000 | +9132.7% | 760,592 | +8101.3% | 0.06% | +5800.0% |
Q4 2016 | $281,000 | -10.5% | 9,274 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $314,000 | +15.9% | 9,274 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $271,000 | +17.3% | 9,274 | +38.7% | 0.00% | 0.0% |
Q4 2015 | $231,000 | – | 6,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,534,664 | $44,720,000 | 5.35% |
Avoro Capital Advisors LLC | 1,325,000 | $38,611,000 | 4.88% |
NEA Management Company, LLC | 3,506,649 | $102,184,000 | 3.72% |
Iguana Healthcare Management, LLC | 140,000 | $4,080,000 | 2.31% |
Foresite Capital Management II, LLC | 135,294 | $3,942,000 | 1.81% |
Foresite Capital Management III, LLC | 176,211 | $5,135,000 | 1.68% |
Abingworth LLP | 70,000 | $2,038,000 | 1.62% |
DAFNA Capital Management LLC | 75,500 | $2,200,000 | 1.57% |
NEXTHERA CAPITAL LP | 120,600 | $3,514,000 | 1.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 129,000 | $3,756,000 | 1.43% |